Upcoming Events
No events are scheduled at this time. Check back for future event information.
Past Events
RSESS Webinar
Update: The UK’s Medicines and Healthcare Products Regulatory Agency
Speaker(s):
David R. Jones, Retired, Expert PharmacoToxicologist, Medicines and Healthcare products Regulatory Agency
Materials:
Webinar Recording
David R. Jones Presentation
September 13, 2023
1 hour 30 minutes
RSESS Webinar
Risk Evaluation of Nongenotoxic Carcinogenic Pharmaceuticals: Impact of The ICH S1B Addendum, A European Viewpoint
Speaker(s):
Jan Willem van der Laan, PhD, Medicines Evaluation Board, European Medicines Agency Representative, ICH S1 Carcinogenicity Regulatory Chair
Materials:
Webinar Recording
van der Laan Presentation
January 17, 2023
1 hour 30 minutes
BTSS and RSESS Joint Webinar
Considerations Regarding Nonhuman Primate Use in Pharmaceutical Development
Speaker(s):
Ronald Wange, PhD, Associate Director for Pharmacology and Toxicology, OND, CDER
Materials:
Webinar Recording
Wange Presentation
Thursday, September 22, 2022
1 hour 30 minutes
RSESS Webinar
Safety of COVID-19 Therapies and Vaccines
Speaker(s):
Kenneth L. Hastings, DrPH, DABT, ATS, Hastings Toxicology Consulting LLC
Materials:
Webinar Recording
Hastings Presentation
Tuesday, June 21, 2022
1 hour 30 minutes
RSESS Virtual Event
Membership Meet & Greet 2022
Wednesday, May 4, 2022
1 hour
LORC & RSESS Webinar
Cannabis: A Review of the Current State of Safety and Regulatory Considerations
Speaker(s):
Tom Jonaitis, DABT
Garrett Graff, Esq.
Materials:
Webinar Recording
Tom Jonaitis, DABT Presentation
Garrett Graff, Esq. Presentation
February 28, 2020
1 hour 15 minutes
RSESS Webinar
Assessment of Adversity and NOAEL in Toxicology Studies to Support Regulatory Decision
Speaker(s):
John L. Vahle, DVM, PhD, DACVP
Vincent Meador, DVM, PhD, DACVP
Materials:
Webinar Recording (Unavailable)
Dr. Vahle Presentation
Dr. Meador Presentation
October 2018
1 hour
GSLC & RSESS Webinar
Finding Your Dream Job in Regulatory Toxicology
Speaker(s):
Edward V. Ohanian, PhD
Amy L. Roe, PhD, DABT
Anne E. Loccisano, PhD, DABT
Materials:
Webinar Recording (Unavailable)
Dr. Ohanian Presentation
Dr. Roe Presentation
Dr. Loccisano Presentation
October 2017
1 hour 32 minutes
RSESS Webinar
Updates for FDA’s GLP Regulations
Speaker(s):
Mark Seaton, PhD, DABT, US FDA
Materials:
Webinar Recording (Unavailable)
Dr. Seaton Presentation
September 2017
1 hour 15 minutes
Regulatory Breakfast Session—RSESS SOT Annual Meeting
First-in-human studies: Recent experiences in Europe
Speaker(s):
Jan Willem van der Laan, Medicines Evaluation Board, Utrecht, The Netherlands
David Jones, MHRA, London, United Kingdom
Materials:
Jan Willem van der Laan Presentation
Lutz Müller Presentation
March 2017
RSESS Webinar
EPA’s Guidelines and Other Related Activities for Cyanotoxins
Speaker(s):
Lesley V. D’Anglada, DrPH, MEH, US Environmental Protection Agency, Washington, DC
February 2017
Great Debate—RSESS SOT Annual Meeting
Precautionary Principle = Risk Assessment (or Not)?
Speaker(s):
Professor Christopher Portier, PhD, FASA, FISI, FWIF, Thun, Switzerland
Professor Alan R. Boobis, OBE, PhD, FRSB, FBTS, Imperial College, London, UK
March 2016
Global Regulations Breakfast—RSESS SOT Annual Meeting
CTA/NDA Regulatory Landscape in China
Speaker(s):
Dr. Jianxun (Jack) Xie, PhD, DABT, Director, Head of Toxicology, Roche Innovation Center Shanghai (China)
Materials:
Presentation
March 2016
RSESS Webinar—Joint Risk Assessment
The Integration of LNT and Hormesis for Cancer Risk Assessment Optimizes Public Health Protection
Speaker(s):
Edward J. Calabrese, Ph.D.
Materials:
Webinar Recording (Unavailable)
Presentation
October 2015
Brown Bag Luncheon—RSESS SOT Annual Meeting
Global Regulatory Toxicology: First Stop EU
Speaker(s):
Beatriz Silva Lima, Universidade de Lisboa, PT, IMI Scientific Committee, BE, NDA Advisory Board, UK
Materials:
Presentation
March 2015
Great Debate—RSESS SOT Annual Meeting
Can/Should Peer-Reviewed Publications Be Used to Formulate Regulatory Policy?
March 2015
Great Debate—RSESS SOT Annual Meeting
HA Mutagen Is a Carcinogen Because It Is a Mutagen
March 2014
Great Debate—RSESS SOT Annual Meeting
Hazard Information Provides an Adequate Basis for Restricting Chemical Use
Speaker(s):
RSESS Past President James C. Lamb, IV, of Exponent
George Gray, George Washington University
Lorenz Rhomberg, Gradient Corporation
Materials:
Debate Flyer
March 2011
Great Debate—RSESS SOT Annual Meeting
Are the Blind Leading the Blind or Are Pathologists Biased? A Debate on the Pros and Cons of Blinded Histopathology Evaluation for the Qualification of New Biomarkers of Toxicity
Speaker(s):
B. Short
K. Pandher
B. Maronpot
Materials:
B. Short Presentation
K. Pandher Presentation
B. Maronpot Presentation
March 2010
Great Debate—RSESS SOT Annual Meeting
Limit the Use of the Non-Rodent in Toxicity Testing: Scientific Considerations
Speaker(s):
Monticello
Olson
Materials:
Monticello Presentation
Olson Presentation
March 2009
Great Debate—RSESS SOT Annual Meeting
MTD: Is Testing to the MTD Unnecessary Animal Use or Always Necessary to Assure Human Safety?
Speaker(s):
Reynolds
Osterberg
Sistare
Materials:
Reynolds Presentation
Osterberg Presentation
Sistare Presentation
March 2008
Great Debate—RSESS SOT Annual Meeting
Ten Years after the Food Quality Protection Act: Healthier Children or Unnecessary Burden?
Speaker(s):
Fenner-Crisp
Faustman
Bus
Materials:
Fenner-Crisp Presentation
Faustman Presentation
Bus Presentation
March 2007
Great Debate—RSESS SOT Annual Meeting
Animal and Human Testing: What’s Appropriate?
Speaker(s):
Doull
Sandusky
Rodricks
Materials:
Doull Presentation
Sandusky Presentation
Rodricks Presentation
March 2006
Great Debate—RSESS SOT Annual Meeting
Rodent Carcinogenicity Assay: Relevant or Relic?
Speaker(s):
Dr. Cohen
Dr. Jacob
Materials:
The Great Debate
Dr. Cohen’s Presentation
Dr. Jacob’s Carcinogenicity Prediction Article
March 2005
Great Debate—RSESS SOT Annual Meeting
Positive Genetic Toxicity Findings: Now What?
Speaker(s):
David Kram
Galloway
Gary Williams
Materials:
David Kram Presentation
Galloway Presentation
Gary Williams Presentation
March 2004